Page 192 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 192

182        ELECTROLYTE DISORDERS



                 keratinizing ameloblastoma. Vet Comp Oncol 2005;3  167. Engelman RW, Tyler RD, Good RA, et al. Hypercalcemia
                 (2):98–100.                                         in cats with feline-leukemia-virus-associated leukemia-
            145. Dhupa N, Proulx J. Hypocalcemia and hypomagnesemia.  lymphoma. Cancer 1985;56:777–81.
                 Vet Clin North Am Small Anim Pract 1998;28:587–608.  168. Estepa JC, Lopez I, Felsenfeld AJ, et al. Dynamics of
            146. DiBartola SP, Chew DJ, Jacobs G. Quantitative urinalysis  secretion and metabolism of PTH during hypo- and
                 including 24-hour protein excretion in the dog. J Am  hypercalcaemia in the dog as determined by the “intact”
                 Anim Hosp Assoc 1980;16:537–46.                     and “whole” PTH assays. Nephrol Dial Transplant
            147. DiBartola SP, Rutgers HC, Zack PM, et al. Clinicopatho-  2003;18:1101–7.
                 logic findings associated with chronic renal disease in cats:  169. Eubig PA, Brady MS, Gwaltney-Brant SM, Khan SA,
                 74  cases  (1973-1984).  J  Am  Vet  Med  Assoc     Mazzaferro EM, Morrow CM. Acute renal failure in dogs
                 1987;190:1196–202.                                  after the ingestion of grapes or raisins: a retrospective eval-
            148. Divieti P, John MR, Juppner H, et al. Human PTH-(7-  uation of 43 dogs (1992-2002). J Vet Intern Med
                 84) inhibits bone resorption in vitro via actions indepen-  2005;19(5):663–74.
                 dent of the type 1 PTH/PTHrP receptor. Endocrinology  170. Falchetti A. Calcium agonists in hyperparathyroidism.
                 2002;143:171–6.                                     Expert Opin Investig Drugs 2004;13:229–44.
            149. Dougherty SA, Center SA, Dzanis DA. Salmon calcitonin  171. Fan TM, de Lorimier LP, Charney SC, et al. Evaluation of
                 as adjunct treatment for vitamin D toxicosis in a dog. J Am  intravenous pamidronate administration in 33 cancer-
                 Vet Med Assoc 1990;196:1269–72.                     bearing dogs with primary or secondary bone involve-
            150. Dow SW, Legendre AM, Stiff M, et al. Hypercalcemia  ment. J Vet Intern Med 2005;19:74–80.
                 associated with blastomycosis in dogs. J Am Vet Med  172. Fan TM, Simpson KW, Trasti S, et al. Calcipotriol toxicity
                 Assoc 1986;188:706–9.                               in a dog. J Small Anim Pract 1998;39:581–6.
            151. Drazner FH. Hypercalcemia in the dog and cat. J Am Vet  173. Farese G, Mager M, Blatt WF. A membrane ultrafiltration
                 Med Assoc 1981;178:1252–6.                          procedure for determining diffusible calcium in serum.
            152. Drobatz KJ, Casey KK. Eclampsia in dogs: 31 cases   Clin Chem 1970;16:226–8.
                 (1995-1998). J Am Vet Med Assoc 2000;217:216–9.  174. Fascetti AJ, Hickman MA. Preparturient hypocalcemia in
            153. Drobatz KJ, Hughes D. Concentration of ionized calcium  four cats. J Am Vet Med Assoc 1999;215:1127–9.
                 in plasma from cats with urethral obstruction. J Am Vet  175. Favus MJ, Langman CB. Evidence for calcium-dependent
                 Med Assoc 1997;211:1392–5.                          control of 1,25-dihydroxyvitamin D3 production by
            154. Drop LJ. Ionized calcium, the heart, and hemodynamic  rat  kidney  proximal  tubules.  J  Biol  Chem
                 function. Anesth Analg 1985;64:432–51.              1986;261:11224–9.
            155. Drueke TB, McCarron DA. Paricalcitol as compared with  176. Favus MJ. Intestinal absorption of calcium, magnesium,
                 calcitriol in patients undergoing hemodialysis. N Engl J  and phosphorus. In: Coe FL, Favus MJ, editors. Disorders
                 Med 2003;349:496–9.                                 of bone and mineral metabolism. New York: Raven Press;
            156. Drueke TB. Cell biology of parathyroid gland hyperplasia  1992. p. 57–81.
                 in  chronic  renal  failure.  J  Am  Soc  Nephrol  177. Feldman EC, Hoar B, Pollard R, Nelson RW.
                 2000;11:1141–52.                                    Pretreatment clinical and laboratory findings in dogs with
            157. Drueke TB. Parathyroid gland hyperplasia in uremia. Kid-  primary hyperparathyroidism: 210 cases (1987-2004).
                 ney Int 2001;59:1182–3.                             J Am Vet Med Assoc 2005;227(5):756–61.
            158. Duncan AR. The use of subcutaneous pamidronate. J Pain  178. Feldman EC, Nelson RW. Hypercalcemia and primary
                 Symptom Manage 2003;26:592–3.                       hyperparathyroidism. In: Feldman EC, editor. Canine
            159. Dusso AS, Finch J, Brown A, et al. Extrarenal production  and feline endocrinology and reproduction. Philadelphia:
                 of calcitriol in normal and uremic humans. J Clin   WB Saunders; 2004. p. 660–715.
                 Endocrinol Metab 1991;72:157–64.                179. Feldman EC, Nelson RW. Hypocalcemia and primary
            160. Dusso AS. Vitamin D receptor: mechanisms for vitamin D  hypoparathyroidism. In: Feldman EC, editor. Canine
                 resistance in renal failure. Kidney Int Suppl 2003;85:  and feline endocrinology and reproduction. Philadelphia:
                 S6–S9.                                              WB Saunders; 2004.
            161. Dust A, Norris AM, Valli VEO. Cutaneous lymphosar-  180. Feldman EC, Wisner ER, Nelson RW, et al. Comparison
                 coma with IgG monoclonal gammopathy, serum hyper-   of results of hormonal analysis of samples obtained from
                 viscosity and hypercalcemia in a cat. Can Vet J     selected venous sites versus cervical ultrasonography for
                 1982;23:235–9.                                      localizing parathyroid masses in dogs. J Am Vet Med
            162. Dzanis DA, Kallfelz FA. Recent knowledge of vitamin D  Assoc 1997;211:54–6.
                 toxicity in dogs. In: Proceedings Am Coll Vet Intern Med  181. Fenton AJ, Kemp BE, Hammonds Jr RG, et al. A potent
                 Forum, vol. 6. 1988.                                inhibitor of osteoclastic bone resorption within a highly
            163. Earm JH, Christensen BM, Frokiaer J, et al. Decreased  conserved pentapeptide region of parathyroid hormone-
                 aquaporin-2 expression and apical plasma membrane   related  protein;  PTHrP[107-111].  Endocrinology
                 delivery in kidney collecting ducts of polyuric hypercalce-  1991;129:3424–6.
                 mic rats. J Am Soc Nephrol 1998;9:2181–93.      182. Fenton AJ, Kemp BE, Kent GN, et al. A carboxyl-terminal
            164. Eelen G, Verlinden L, van Camp M, et al. The effects of  peptide from the parathyroid hormone-related protein
                 1alpha,25-dihydroxyvitamin D3 on the expression of  inhibits bone resorption by osteoclasts. Endocrinology
                 DNA   replication  genes.  J  Bone  Miner  Res      1991;129:1762–8.
                 2004;19:133–46.                                 183. Finco DR, Rowland GN. Hypercalcemia secondary to
            165. Eiam-Ong S, Punsin P, Sitprija V, et al. Acute hypercalce-  chronic renal failure in the dog: a report of four cases.
                 mia-induced hypertension: the roles of calcium channel  J Am Vet Med Assoc 1978;173:990–4.
                 and alpha-1 adrenergic receptor. J Med Assoc Thai  184. Finco DR. Interpretations of serum calcium concentra-
                 2004;87:410–8.                                      tion in the dog. Comp Contin Educ 1983;5:778–87.
            166. ElliottJ,DobsonJ,DunnJ,etal.Hypercalcemiainthedog:a  185. Fingeroth JM, Smeak DD. Intravenous methylene blue
                 study of 40 cases. J Small Anim Pract 1991;32:564–71.  infusion for intraoperative identification of parathyroid
   187   188   189   190   191   192   193   194   195   196   197